Legal Alliance Company as well as its legal experts was recognized by the prestigious international catalogue The Legal 500 in the spheres of Corporate, Commercial and M&A, and Intellectual Property.
In particular it was noted that:
Corporate, Commercial and M&A.“At Legal Alliance Company, Illya Kostin andNatalia Lavrenova are noted for their ‘positive collaboration’ and ability to ‘always meet clients’ expectations’.
Intellectual Property. “Legal Alliance Company is ‘prompt and efficient, and has in-depth knowledge of the pharmaceutical industry’. Oleksiy Bezhevets is ‘calm and solution-oriented’; Dmytro Aleshko is ‘second to none on regulatory law’; and Andrii Gorbatenko has ‘in-depth knowledge of anti-monopoly law’.
Ilya Kostin, Legal Alliance Partner, commented: “Legal Alliance team highly appreciates this ranking based on our clients’ feedback and consider it as a good motivation to continue improving our legal services”.
****
For 28 years, The Legal 500 has been analyzing the capabilities of law firms across the world, with a comprehensive research programme revised and updated every year to bring the most up-to-date vision of the global legal market. The Legal 500 assesses the strengths of law firms in over 100 jurisdictions. The research is based on feedback from 250,000 clients worldwide, submissions from law firms and interviews with leading private practice lawyers, and a team of researchers who have unrivalled experience in the legal market.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
